Skip to main content

Dovato

NDC 49702-246 · ViiV Healthcare Company

Generic namedolutegravir sodium and lamivudine
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)DOLUTEGRAVIR SODIUM, LAMIVUDINE
Strength50; 300 mg/1; mg/1
Pharmacologic classHIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
Marketing categoryNDA

Packages

49702-246-13 — 30 TABLET, FILM COATED in 1 BOTTLE (49702-246-13)

49702-246-33 — 1 BLISTER PACK in 1 CARTON (49702-246-33) / 30 TABLET, FILM COATED in 1 BLISTER PACK

49702-246-62 — 1 BLISTER PACK in 1 CARTON (49702-246-62) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

49502-475 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 49702-202 — lamivudine and zidovudine, 49702-203 — lamivudine, 49702-204 — lamivudine, 49702-205 — lamivudine, 49702-226 — dolutegravir sodium, 49702-227 — dolutegravir sodium, 49702-228 — dolutegravir sodium, 49702-231 — abacavir sulfate, dolutegravir sodium, lamivudine, 49702-242 — dolutegravir sodium and rilpivirine hydrochloride, 49702-255 — dolutegravir sodium, 50742-623 — Lamivudine, 50742-624 — Lamivudine, 51407-866 — Lamivudine, 57237-274 — Lamivudine, 60429-353 — lamivudine, 60429-354 — lamivudine, 60505-3250 — Lamivudine, 60505-3251 — lamivudine, 60505-3252 — lamivudine, +38 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.